About

About Svar
Career
Distributors
Events

Products

All Products
Complement Assays
Cell-Based Assays
Gene Therapy Assays
CCP Assays

Services

CRO Services
Diagnostic Services
Custom Cell Development
Cell Manufacturing

Applications

Knowledge

Knowledge Hub
Scientific Publications
Videos & Webinars
Product Documentation

Svar offers a unique combination of scientific expertise, high-quality assay products, strong services, and proprietary technology platforms that provide a flexible and seamless experience for different customer needs.

About Svar

Life science is always asking new questions. It's essential to the discovery process.

Career

We are always interested in finding new talented individuals to join our team, from new graduates to experienced professionals.

Work with Us

Distributors

We collaborate with our valued distributors to provide our technology to end customers worldwide, leveraging our distributors' local knowledge and expertise

Our Distributors

Events

Join us at leading life science events worldwide. Explore our Event Calendar for a full-year view of major conferences and scientific gatherings.

Meet Us at an Event

View our comprehensive portfolio of products for drug development and patient diagnosis and monitoring

All Products

Our products are trusted worldwide in research, clinical, and commercial laboratory settings.

Our Products

Complement Assays

Functional and biomarker assays for the exploration of every angle of the complement system

Complement Products

Cell-Based Assays

Our cell-based bioassays are based on iLite^® technology – a cleverly designed cell-based assay system with reporter gene readouts

Gene Therapy Assays

AAV Neutralizing Antibody (NAb), Total Antibody (TAb), and Complement Activation assays designed to provide a comprehensive view of vector immunogenicity

CCP Assays

Solutions for detecting and semi-quantitating IgG antibodies against CCP

CCP Assays

We offer high-quality flexible services in many areas within life science. Our CRO Services offer extensive bioanalytical, biomarker discovery, and QC testing services in a GMP setting.

In addition, we offer expert diagnostic services for autoimmune and neurological disorders, as well as cell and manufacturing services.

CRO Services

Our extensive CRO Services offer bioanalysis, biomarker discovery, and GMP QC testing.

Diagnostic Services

With over 30 years of experience in autoimmune diagnostics, our ISO15189-certified specialist laboratory can help you reach the correct diagnosis. We also provide testing services and support for therapeutic drug monitoring.

Custom Cell Development

Let us develop a custom iLite^® cell line tailored to your needs.

iLite^® Custom Cell Lines

Cell Manufacturing

Our cell services are highly reliable and innovative, tailored to your manufacturing needs

Our solutions for drug development, diagnostics, and regulatory compliance – covering everything from therapeutic applications and biomarker testing to bioanalysis and quality assurance

Potency Testing

Explore how our expertise in potency testing, functional characterization, and immunogenicity assessment can support your drug development journey from discovery through regulatory submission

Potency Testing

Safety Assessment

Ensure therapeutic safety with our immunogenicity assays, hemocompatibility panels, and complement pathway testing designed to meet global regulatory standards.

Safety Assessment

Biomarker Profiling

From multiplex ELISA to custom biomarker assay development, we help you generate actionable insights for precision medicine.

Biomarker Profiling

Clinical Assessment

Our CE-marked diagnostic kits and specialized services enable accurate disease detection and patient stratification for personalized treatment strategies.

Clinical Assessment

Bioanalysis

Our GLP-compliant bioanalytical services provide accurate PK, TK, and PD data through optimized workflows and sensitive biomarker assays for regulatory success.

Bioanalysis (PK/TK/PD) – GLP Compliant

Regulatory Testing

Achieve full regulatory compliance with our GMP-qualified QC testing for biologics and biosimilars, ISO 15189-accredited diagnostic services, and customized cell-based solutions.

Regulated Testing

Complement System Evaluation

Access a complete portfolio of complement ELISAs, biomarker panels, and functional assays to evaluate complement pathways and support safety and efficacy studies.

Complement System Evaluation

Gene & Cell Therapy Evaluation

Accelerate advanced therapy development with our custom potency assays, AAV-specific safety platforms, and mechanism-of-action reflective cell-based solutions backed by GMP expertise.

Gene & Cell Therapy Evaluation

Biosimilar & Biobetter Assessment

Demonstrate comparability and functional performance with our side-by-side assay panels, Fc-effector function testing, and iLite® bioassays tailored for biosimilars and biobetters.

Biosimilar & Biobetter Assessment

Valuable resources, downloads, and more. Get the latest white papers, safety data sheets, and instruction manuals

Knowledge Hub

Read our Science Insights about topics related to our areas of expertise. Browse our Expert Perspectives to explore case studies, interviews with scientists, and more.

Scientific Publications

Explore our collection of white papers, technical notes, posters, and our list of peer-reviewed publications highlighting how our technologies are used across diverse applications.

Videos & Webinars

Watch our webinars and videos designed to inform, educate, and explain.

Videos and Webinars

Product Documentation

Instruction manuals, safety data sheets, certificates, and more for Svar's products.

Product Documentation

BM5028 iLite® CD20 (+) Svar Luc Assay Ready Cells
BM5001 iLite® ADCC Effector FcγRIIIa (V)
BM5004 iLite® ADCP Effector FcγRIIa
BM4075 iLite® C5a Assay Ready Cells
BM3044 iLite® TNF-alpha Assay Ready Cells
BM4052 iLite® RANKL Assay Ready Cells
BM4044 iLite® TNF-alpha Xcel Assay Ready Cells
BM4049 iLite® Type I IFN FAST Assay Ready Cells
BM3071 iLite® FGF-21 Assay Ready Cells
BM4055 iLite® G-CSF Assay Ready Cells
BM4050 iLite® GM-CSF Assay Ready Cells
BM4021 iLite® VEGF Assay Ready Cells
BM4080 iLite® hCG Assay Ready Cells
BM3060 iLite® Insulin Assay Ready Cells
BM4023 iLite® IL-23 Assay Ready Cells
BM4012 iLite® IL-12 Assay Ready Cells
BM4002 iLite® IL-2 Assay Ready Cells
BM4061 iLite® IL-6 Assay Ready Cells
BM4025 iLite® TLR4 Assay Ready Cells
BM6069 iLite® TLR9 Assay Ready Cells
BM6100 iLite® AAV Responsive Reporter Assay Ready Cells
BM6002 iLite® AAV2 Packaging Assay Ready Cells
BM6005 iLite® AAV5 Packaging Assay Ready Cells
BM6006 iLite® AAV6 Packaging Assay Ready Cells
BM6008 iLite® AAV8 Packaging Assay Ready Cells
BM6009 iLite® AAV9 Packaging Assay Ready Cells
BM5005 iLite® CD3 Effector
BM5025 iLite® CD19 (+) Target
BM5026 iLite® CD19 (-) Target
BM5010 iLite® CD20 (+) Target
BM5015 iLite® CD20 (-) Target
BM5035 iLite® EGFR (+) Target
BM5036 iLite® EGFR (-) Target
BM5011 iLite® HER2 (+) Target
BM5016 iLite® HER2 (-) Target
BM5013 iLite® mTNF-alpha (+) Target
BM5014 iLite® mTNF-alpha (-) Target
BM5017 iLite® mVEGF (+) Target
BM5018 iLite® mVEGF (-) Target
COMPL C4d RUO Complement C4d
COMPL FPQ RUO Complement Factor P Quantitative Assay
COMPL TCC RUO Complement TCC
COMPL FPF RUO Complement Factor P Functional Assay
COMPLAP330 WIESLAB® Complement Alternative Pathway
COMPLAP330RUO WIESLAB® Complement Alternative Pathway (RUO)
COMPLCP310 WIESLAB® Complement Classical Pathway
COMPLCP310RUO WIESLAB® Complement Classical Pathway (RUO)
COMPLMP320 WIESLAB® Complement MBL Pathway
COMPLMP320RUO WIESLAB® Complement MBL Pathway (RUO)
COMPL300 WIESLAB® Complement Screen
COMPL300RUO WIESLAB® Complement Screen (RUO)
RA-96 PLUS IMMUNOSCAN CCPlus®
RA-96 PLUS RUO IMMUNOSCAN CCPlus® - RUO
008 C-/P-ANCA
017 Cardiolipin Antibodies (IgA)
018 Autoimmune Liver Disease Screen
020 ANA (HEp-2)
023 dsDNA Antibodies (IgG)
024 ANA Specificities
025 Sm Antibodies
027 SSA/Ro60 Antibodies
028 SSB/La Antibodies
031 Ribosomal P-Protein (Ribo-P) Antibodies
032 SSA/Ro52 Antibodies
047 FGFR3 Antibodies (IgG)
071 Endomysial Antibodies (IgA)
074 Transglutaminase Antibodies (IgA)
079 Acetylcholine Receptor Antibodies
082 Smooth Muscle Antibodies (SMA)
084 Mitochondrial Antibodies (AMA)
085 Striational Antibodies
086 Adrenal Cortex Antibodies
087 Parietal Cell Antibodies
089 GAD Antibodies
090 Islet Cell Antibodies
093 MAG Antibodies
095 HSP-70 Antibodies
098 Histone Antibodies
100 GBM Antibodies (IgG4)
110 Insulin Antibodies
111 IA-2 Antibodies
113 ZnT8 Antibodies
117 mGluR1 Antibodies (IgG)
118 mGluR5 Antibodies (IgG)
119 Neurofilament Heavy Chain (pNfH)
140 THSD7A Antibodies (IgG)
141 cN-1A (Mup44) Antibodies (IgG)
146 Beta-2-Glycoprotein Antibodies (IgA)
205 Envoplakin Antibodies (IgG)
220 Hu (ANNA-1) Antibodies (IgG)
240 Streptolysin O Antibodies
247 PLA2R Antibodies ELISA (IgG)
280 Collagen Type VII IgG Antibodies (IgG)
291 HLA-DQB1*06:02 (Narcolepsy)
355 Sulfatide Antibodies (IgM)
450 RNA Polymerase Antibodies
485 HMGCR Antibodies
500 Glomerulonephritis – Extended Analysis
501 ANCA Vasculitis/Anti-GBM Disease (Goodpasture Syndrome)
510 Antiphospholipid Syndrome (APS)
511 Systemic Lupus Erythematosus (SLE)/Sjogren's Syndrome
515 Autoimmune Liver Disease
516 Cardiolipin Antibodies (IgG, IgM)
517 Beta-2-Glycoprotein 1 Antibodies (IgG, IgM)
522 Systemic Sclerosis/Scleroderma
527 Systemic Sclerosis/Scleroderma – Extended Analysis
530 Sudden Deafness
531 Diabetes Mellitus Type 1
534 Guillain-Barré Syndrome/AIDP
620 Autoimmune Nodopathy/CIDP – Screen IgG
533 Autoimmune Nodopathy/CIDP – Extended Analysis with Reflex (IgG1-4)
541 Drug Induced Lupus
543 Myasthenia Gravis
548 Myositis/ Interstitial Lung Disease (ILD) Screen
550 Bullous Dermatosis
555 Inflammatory Myopathies (Myositis)/Interstitial Lung Disease (ILD)
563 Lambert Eatons Myastena Syndrome (LEMS)
566 CNS Tissue Damage Biomarker
568 Stiff Person Syndrome
569 Paraneoplastic Retinopathy Syndrome (MAR/CAR)
571 Hereditary Angioedema (HAE)
572 Complement Deficiency
584 Primary Membranous Nephropathy (PMN)
575 Autoimmune Pancreatitis Type 2 (AIP2)
600 Fibrillarin Antibodies
546 Ganglioside Antibodies (IgG, IgM)
710 PM/Scl (100kD) Antibodies
720 Th/To Antibodies
730 Amphiphysin Antibodies (IgG)
736 Recoverin Antibodies (IgG)
737 SOX1 Antibodies (IgG)
740 Yo (Purkinje cell) Antibodies (IgG)
742 Zic4 Antibodies (IgG)
750 Ri (Nova 1/ ANNA-2) Antibodies (IgG)
760 Tr Antibodies (IgG)
761 PCA-2 Antibodies
772 AMPA Receptor 1/2 Antibodies (IgG)
780 21-Hydroxylase Antibodies
790 Ma (Ma-2/Ta) Antibodies (IgG)
831 VGKC Antibodies (IgG)
833 LGI-1 Antibodies (IgG)
835 CASPR2 Antibodies (IgG)
837 Alpha-Enolase Antibodies
838 Glycine Receptor Antibodies (IgG)
839 Ryanodin Receptor 1 (RyR1) Antibodies
845 VGCC Antibodies
850 Carbonic Anhydrase II Antibodies
851 DPPX Antibodies (IgG)
852 IgLON5 Antibodies (IgG)
854 CARP VIII Antibodies (IgG)
855 HOMER3 Antibodies (IgG)
856 ITPR1 Antibodies (IgG)
859 Lactoferrin (DNA-Bound) Antibodies (IgG)
870 CV2/CRMP5 Antibodies (IgG)
874 ANNA-3 Antibodies
875 NMDA Receptor Antibodies (IgG)
877 GABA B Receptor Antibodies (IgG)
880 Aquaporin 4 (AQP4) Antibodies (IgG)
884 MOG Antibodies (IgG)
890 C1q Antibodies
920 C1q
925 C1 INH Level
930 C3d
958 Lrp4 Antibodies
959 Ganglionic AChR Antibodies
960 MuSK Antibodies (IgG)
965 Titin Antibodies (IgG)
970 Trib2 Antibodies
988 CXCL13
989 Orexin (Hypokretin-1)
990 Tau
991 pTau
992 Beta-Amyloid 42
994 Neurofilament Light (NfL)
260, 282 Bullous Pemphigoid (BP180/BP230) Antibodies (IgG)
403 Phosphatidylserine Antibodies (IgGAM)
404 Phosphatidylserine Antibodies (IgA)
405 Phosphatidylserine Antibodies (IgG)
406 Phosphatidylserine Antibodies (IgM)
460, 470 Desmoglein 1 and 3 Antibodies (IgG)
900 C3
910 C4
565 Neuromyelitis Optica Spectrum Disorder (NMOSD)/MOGAD
549 Neuromyelitis Optica Spectrum Disorder – Tissue Damage Biomarkers
536 BPI-ANCA (IgG, IgA)
573 Complement Function
931 Properdin
520 Systemic Inflammatory Disease
567 Alzheimer's Disease Biomarkers
579 Antiphospholipid Syndrome (APS) – Extended Analysis
570 Complement Activation
836 CASPR1 Antibodies (IgG)
997 Beta Amyloid Ratio 42/40
926 C1 INH Function
996 GFAp Antibodies (IgG)
581 Multiple Sclerosis (MS)
580 Amyotrophic Lateral Sclerosis (ALS) Biomarkers
585 Autoimmune Epilepsy
586 Autoimmune Epilepsy – Extended Analysis
872 Neurexin-3 Alpha Antibodies (IgG)
876 GABA A Receptor Antibodies (IgG)
080 Agrin Antibodies
052 Dopamin-2 Receptor Antibodies (IgG)
871 Neurochondrin Antibodies (IgG)
804 TS-HDS Antibodies (IgM)
986 Neurogranin
535 Small Fiber Neuropathy (SFN)
195 Autoimmune Encephalitis
199 Paraneoplastic Syndrome (IIF and Immunoblot)
560 Autoimmune Encephalitis, Paraneoplastic Syndrome & Cerebellar Ataxia
562 Neuronal Antibodies – Extended Analysis
587 Pediatric Autoimmune Encephalitis
574 Ophelia’s Syndrome (Paraneoplastic Cerebellar Ataxia or Limbic Encephalitis)
588 Pediatric Autoimmune Encephalitis – Extended Analysis
987 pTau-181
805 Plexin D1 Antibodies (IgG)
539 Small Fiber Neuropathy (SFN) – Extended Analysis
878 Sez6L2 Antibodies (IgG)
011 PR3-ANCA (IgG)
015 MPO-ANCA (IgG)
002 GBM Antibodies (IgG)
245 PLA2R Antibodies IIF (IgG)
294 ApoE4 Genotyping
868 KCNA2 antibodies (IgG)
557 Alzheimer's Disease Biomarkers – Extended Analysis
124 Infliximab
126 Adalimumab
128 Etanercept
130 Golimumab
132 Certolizumab
138 Vedolizumab
605 Ustekinumab
136 Natalizumab
613 Eculizumab
603 Rituximab
615 Abatacept
607 Tocilizumab
105 Erythropoietin
957 KLHL11 Antibodies (IgG)
558 Narcolepsy
540 Autoimmune nodopathy/CIDP – subclass screen (IgG1-4)
883 Aquaporin 4 (AQP4) Antibodies (IgG) – Live CBA
885 MOG Antibodies (IgG) – Live CBA
561 Neuromyelitis Optica Spectrum Disorder (NMOSD)/MOGAD – Live CBA
985 Glial Fibrillary Acidic Protein (GFAP)

iLite
Complement
Calpro

Svar News

Stay up to date with the latest developments, announcements, and expert perspectives. Get company updates, the latest life science trends, thought leadership articles, and event highlights – all designed to keep you up to date.

FILTER VIEW

ALL COMPLEMENT SYSTEM CELL-BASED TECHNOLOGY SVAR CRO SERVICES GENERAL NEWS

The Importance of Early and Accurate Diagnosis in Autoimmune Encephalitis

WIESLAB DIAGNOSTIC SERVICES

The Importance of Early and Accurate Diagnosis in Autoimmune Encephalitis

Introducing the new iLite® C3a Assay Ready Cells

COMPLEMENT SYSTEM

Introducing the new iLite^® C3a Assay Ready Cells

Celebrating 20 Years of the Wieslab Complement System Assays

COMPLEMENT SYSTEM

Celebrating 20 Years of the Wieslab Complement System Assays

Shaping the Future of Immuno-Driven Innovation: From a Legacy in Complement to Advancements in New Modalities

Shaping the Future of Immuno-Driven Innovation: From a Legacy in Complement to Advancements in New Modalities

The Role of Laboratory Testing in the Diagnosis of Alzheimer’s Disease

WIESLAB DIAGNOSTIC SERVICES

The Role of Laboratory Testing in the Diagnosis of Alzheimer’s Disease

Navigating Regulatory Changes: Our Commitment to Customers During the IVDR Transition

Navigating Regulatory Changes: Our Commitment to Customers During the IVDR Transition

Navigating Regulatory Changes: The Importance of IVDR in the Clinical Diagnostics Market

Navigating Regulatory Changes: The Importance of IVDR in the Clinical Diagnostics Market

Take advantage of a more comprehensive way of looking at AAV Immunogenicity – With a Partner Who Gets the full picture

COMPLEMENT SYSTEM

Take advantage of a more comprehensive way of looking at AAV Immunogenicity – With a Partner Who Gets the full picture

Introducing the AAV Complement Activation Assay: A New Standard in Safety Assessment for Gene Therapies

COMPLEMENT SYSTEM

Introducing the AAV Complement Activation Assay: A New Standard in Safety Assessment for Gene Therapies

Bridging Analytical Power: Integrating LC-MS and Ligand Binding Assays for Modern Bioanalysis

SVAR CRO SERVICES

Bridging Analytical Power: Integrating LC-MS and Ligand Binding Assays for Modern Bioanalysis

Advancing Gene Therapy Research with iLite Assay Ready Cells for AAV Neutralizing Antibody Detection

COMPLEMENT SYSTEM

Advancing Gene Therapy Research with iLite Assay Ready Cells for AAV Neutralizing Antibody Detection

AAV Safety Assay Platform: The Immunogenicity Trifecta - NAb, TAb & Complement

COMPLEMENT SYSTEM

AAV Safety Assay Platform: The Immunogenicity Trifecta - NAb, TAb & Complement

Exploring Gene Therapy: Modalities, Immunogenicity, and Potency

COMPLEMENT SYSTEM

Exploring Gene Therapy: Modalities, Immunogenicity, and Potency

Harnessing Complement Biomarkers in Cancer and Infectious Disease Research

COMPLEMENT SYSTEM

Harnessing Complement Biomarkers in Cancer and Infectious Disease Research

Navigating Regulatory Changes: Benefits of IVDR Compliance

Navigating Regulatory Changes: Benefits of IVDR Compliance

PRESS RELEASE: Svar Life Science & Lablytica Life Science Announce Strategic Partnership to Expand Bioanalytical Services with Advanced LC-MS/MS Capabilities

SVAR CRO SERVICES

PRESS RELEASE: Svar Life Science & Lablytica Life Science Announce Strategic Partnership to Expand Bioanalytical Services with Advanced LC-MS/MS Capabilities

In Support for World MS Day

WIESLAB DIAGNOSTIC SERVICES

In Support for World MS Day

Advancements in Complement System Therapeutics

COMPLEMENT SYSTEM

Advancements in Complement System Therapeutics

Investing in the Future: Wieslab Functional Complement & CCP Kit

Investing in the Future: Wieslab Functional Complement & CCP Kit

Targeting the Complement System: A New Era in Disease Treatment

COMPLEMENT SYSTEM

Targeting the Complement System: A New Era in Disease Treatment

Understanding IVDR Compliance: What It Means for Clinical Diagnostic Applications

Understanding IVDR Compliance: What It Means for Clinical Diagnostic Applications

Gearing for the Future - Navigating Regulatory Changes Together

Gearing for the Future - Navigating Regulatory Changes Together

Optimizing Your Bioassays: Transitioning to Second-Generation iLite® Cells

CELL-BASED TECHNOLOGY

Optimizing Your Bioassays: Transitioning to Second-Generation iLite^® Cells

Faster detection and enhanced accuracy in immunogenicity detection

CELL-BASED TECHNOLOGY

Faster detection and enhanced accuracy in immunogenicity detection

New Test: GFAP in serum

WIESLAB DIAGNOSTIC SERVICES

New Test: GFAP in serum

Overcoming Immunogenicity Challenges in Therapeutic Antibodies

Overcoming Immunogenicity Challenges in Therapeutic Antibodies

Understanding the immune response to therapeutic antibodies: Insights from recent research

Understanding the immune response to therapeutic antibodies: Insights from recent research

Driving Discovery: 600+ Studies Featuring Our Immunoassays & Cell-Based Assays

Driving Discovery: 600+ Studies Featuring Our Immunoassays & Cell-Based Assays

World Encephalitis Day

WIESLAB DIAGNOSTIC SERVICES

World Encephalitis Day

Wieslab has received a renewed ISO 15189 certificate

WIESLAB DIAGNOSTIC SERVICES

Wieslab has received a renewed ISO 15189 certificate

Live Cell-Based Assays

WIESLAB DIAGNOSTIC SERVICES

Live Cell-Based Assays

EMCHD 2024: Pioneering Breakthroughs in Complement Research and Therapeutics

COMPLEMENT SYSTEM

EMCHD 2024: Pioneering Breakthroughs in Complement Research and Therapeutics

First CRO certified for Olink Proteomics Services in the Nordics!

SVAR CRO SERVICES

First CRO certified for Olink Proteomics Services in the Nordics!

Test Portfolio Updates

WIESLAB DIAGNOSTIC SERVICES

Test Portfolio Updates

World Alzheimer's Day: Raising Awareness

WIESLAB DIAGNOSTIC SERVICES

World Alzheimer's Day: Raising Awareness

Understanding Neuromyelitis Optica Spectrum Disorder & Myelin Oligodendrocyte Glycoprotein Associated Disease

WIESLAB DIAGNOSTIC SERVICES

Understanding Neuromyelitis Optica Spectrum Disorder & Myelin Oligodendrocyte Glycoprotein Associated Disease

New Panel: Alzheimer’s Disease Biomarkers – Extended Panel

WIESLAB DIAGNOSTIC SERVICES

New Panel: Alzheimer’s Disease Biomarkers – Extended Panel

Customized Solutions in AAV-Mediated Gene Therapy: Moving Beyond the One-Size-Fits-All Approach

Customized Solutions in AAV-Mediated Gene Therapy: Moving Beyond the One-Size-Fits-All Approach

Testing for Autoimmune Nodopathy

WIESLAB DIAGNOSTIC SERVICES

Testing for Autoimmune Nodopathy

Decoding Pre-existing Antibodies Towards AAV Capsids to Optimize Gene Therapy Outcomes

Decoding Pre-existing Antibodies Towards AAV Capsids to Optimize Gene Therapy Outcomes

Assess Your Antibodies from Every Angle: The Importance of Orthogonal Assays in Monoclonal Antibody Activity Characterization

COMPLEMENT SYSTEM

Assess Your Antibodies from Every Angle: The Importance of Orthogonal Assays in Monoclonal Antibody Activity Characterization

Svar Complement Excellence Award 2024

COMPLEMENT SYSTEM

Svar Complement Excellence Award 2024

Upcoming Webcast - AAV safety and potency: exploring the analytical maze of gene therapy

COMPLEMENT SYSTEM

Upcoming Webcast - AAV safety and potency: exploring the analytical maze of gene therapy

Development and characterization of narsoplimab a selective MASP-2 inhibitor, for the treatment of lectin-pathway-mediated disorders

COMPLEMENT SYSTEM

Development and characterization of narsoplimab a selective MASP-2 inhibitor, for the treatment of lectin-pathway-mediated disorders

Encephalitis Webinar: Brains on Fire

WIESLAB DIAGNOSTIC SERVICES

Encephalitis Webinar: Brains on Fire

Reflecting on a decade of collaboration excellence

WIESLAB DIAGNOSTIC SERVICES

Reflecting on a decade of collaboration excellence

Optimizing AAV Gene Therapy: Overcoming Immune Barriers for Enhanced Safety and Efficacy

CELL-BASED TECHNOLOGY

Optimizing AAV Gene Therapy: Overcoming Immune Barriers for Enhanced Safety and Efficacy

Perspectives on Therapeutics Development in 2024: Exploring New Frontiers

COMPLEMENT SYSTEM

Perspectives on Therapeutics Development in 2024: Exploring New Frontiers

10 Years of Autoimmune Encephalitis Testing

WIESLAB DIAGNOSTIC SERVICES

10 Years of Autoimmune Encephalitis Testing

The Importance of Complement Biomarkers in Advancing Therapeutic Development

COMPLEMENT SYSTEM

The Importance of Complement Biomarkers in Advancing Therapeutic Development

Introducing iLite® AAV NAb platform for Immunogenicity testing

COMPLEMENT SYSTEM

Introducing iLite^® AAV NAb platform for Immunogenicity testing

Understanding Complement-Dependent Cytotoxicity (CDC) in Therapeutics: Key Insights for Developing Complement Modulators

COMPLEMENT SYSTEM

Understanding Complement-Dependent Cytotoxicity (CDC) in Therapeutics: Key Insights for Developing Complement Modulators

New Urgent HMGCR Antibody Testing

WIESLAB DIAGNOSTIC SERVICES

New Urgent HMGCR Antibody Testing

Presenting the Ultimate iLite® Complement-Dependent Cytotoxicity (CDC) Bioassay Solution with Extended Adaptation Capabilities

COMPLEMENT SYSTEM

Presenting the Ultimate iLite^® Complement-Dependent Cytotoxicity (CDC) Bioassay Solution with Extended Adaptation Capabilities

Svar Supporting the EPND Initiative: Advancing Awareness and Treatment for Neurodegenerative Diseases on World Alzheimer's Day

Svar Supporting the EPND Initiative: Advancing Awareness and Treatment for Neurodegenerative Diseases on World Alzheimer's Day

Diagnostic Panel Updates & Scientific Highlights

WIESLAB DIAGNOSTIC SERVICES

Diagnostic Panel Updates & Scientific Highlights

Strengthening our Biomarker Discovery Services – unboxing new cutting-edge technology!

Strengthening our Biomarker Discovery Services – unboxing new cutting-edge technology!

Optimization of a High-Throughput Cell-Based Screening Strategy to Identify Small-Molecule Inhibitors of IL-23 Signaling

CELL-BASED TECHNOLOGY

Optimization of a High-Throughput Cell-Based Screening Strategy to Identify Small-Molecule Inhibitors of IL-23 Signaling

PRESS RELEASE: Svar Life Science adopts Olink’s Novel Proteomics Solutions Technology to strengthen position as a Biomarker Discovery Services partner

SVAR CRO SERVICES

PRESS RELEASE: Svar Life Science adopts Olink’s Novel Proteomics Solutions Technology to strengthen position as a Biomarker Discovery Services partner

Heating-mediated purification of active FGF21 and structure-based design of its variant with enhanced potency

CELL-BASED TECHNOLOGY

Heating-mediated purification of active FGF21 and structure-based design of its variant with enhanced potency

Antibody-Positive Autoimmune Encephalitis and Paraneoplastic Neurological Syndrome: Epidemiology and Outcome of Neuronal Antibody Testing in Sweden

WIESLAB DIAGNOSTIC SERVICES

Antibody-Positive Autoimmune Encephalitis and Paraneoplastic Neurological Syndrome: Epidemiology and Outcome of Neuronal Antibody Testing in Sweden

The Importance of Timing and CRO Expertise in Drug Development

SVAR CRO SERVICES

The Importance of Timing and CRO Expertise in Drug Development

Advancements in GMP QC Testing: A Comprehensive Guide to Cell-Based Assays

SVAR CRO SERVICES

Advancements in GMP QC Testing: A Comprehensive Guide to Cell-Based Assays

First-in-human study with SAR445088: A novel selective classical complement pathway inhibitor

COMPLEMENT SYSTEM

First-in-human study with SAR445088: A novel selective classical complement pathway inhibitor

Wieslab's Quick Guide 2023

WIESLAB DIAGNOSTIC SERVICES

Wieslab's Quick Guide 2023

Wieslab's Newsletter and Scientific Highlights – Spring 2023

WIESLAB DIAGNOSTIC SERVICES

Wieslab's Newsletter and Scientific Highlights – Spring 2023

Analysis of Bevacizumab Activity Following Treatment of Patients with Ovarian Cancer or Glioblastoma

CELL-BASED TECHNOLOGY

Analysis of Bevacizumab Activity Following Treatment of Patients with Ovarian Cancer or Glioblastoma

PRESS RELEASE: Svar Life Sciences to offer GMP potency testing using cell-based Bioassays

SVAR CRO SERVICES

PRESS RELEASE: Svar Life Sciences to offer GMP potency testing using cell-based Bioassays

Next-Generation Complement Therapeutics — Exploring Challenges and Solutions from Bench to Bedside, Upcoming Webinar featuring Svar Life Science

COMPLEMENT SYSTEM

Next-Generation Complement Therapeutics — Exploring Challenges and Solutions from Bench to Bedside, Upcoming Webinar featuring Svar Life Science

Properdin functional and quantitative assays: a new bi-dimensional tool boosting the next generation of complement therapeutics

Properdin functional and quantitative assays: a new bi-dimensional tool boosting the next generation of complement therapeutics

Rare Disease Awareness Day - The importance of new Complement therapeutics

COMPLEMENT SYSTEM

Rare Disease Awareness Day - The importance of new Complement therapeutics

Time is Brain: early diagnosis is vital for Encephalitis

WIESLAB DIAGNOSTIC SERVICES

Time is Brain: early diagnosis is vital for Encephalitis

Bioassay Services in a GMP environment – coming soon!

Bioassay Services in a GMP environment – coming soon!

Svar – a part of the future of Swedish-Danish Life Science

Svar – a part of the future of Swedish-Danish Life Science

Wieslab's Newsletter and Scientific Highlights – Autumn 2022

WIESLAB DIAGNOSTIC SERVICES

Wieslab's Newsletter and Scientific Highlights – Autumn 2022

Wieslab offers a new Small Fiber Neuropathy panel for extended testing

WIESLAB DIAGNOSTIC SERVICES

Wieslab offers a new Small Fiber Neuropathy panel for extended testing

Wieslab now offers pTau-181 testing – a piece of the puzzle in the early diagnosis of Alzheimer's Disease

WIESLAB DIAGNOSTIC SERVICES

Wieslab now offers pTau-181 testing – a piece of the puzzle in the early diagnosis of Alzheimer's Disease

Wieslab Diagnostic Services is proud to raise awareness of the importance of early diagnosis of Alzheimer's Disease.

WIESLAB DIAGNOSTIC SERVICES

Wieslab Diagnostic Services is proud to raise awareness of the importance of early diagnosis of Alzheimer's Disease.

Svar Life Science Group Appoints Anne Thjømøe As New CEO

Svar Life Science Group Appoints Anne Thjømøe As New CEO

New tests & updates to our 2022 Diagnostic Test Portfolio

WIESLAB DIAGNOSTIC SERVICES

New tests & updates to our 2022 Diagnostic Test Portfolio

New interactive publication about Danish-Swedish Life Science Cluster

New interactive publication about Danish-Swedish Life Science Cluster

Svar Complement Excellence Award 2022

COMPLEMENT SYSTEM

Svar Complement Excellence Award 2022

The development of robust cell-based assays for gene therapy: Behind the scenes at Novartis

SVAR CRO SERVICES

The development of robust cell-based assays for gene therapy: Behind the scenes at Novartis

Wieslab Diagnostic Services App - Your extensive test guide

WIESLAB DIAGNOSTIC SERVICES

Wieslab Diagnostic Services App - Your extensive test guide

Robert “Bob” Braidwood Sim Memorial Symposium

COMPLEMENT SYSTEM

Robert “Bob” Braidwood Sim Memorial Symposium

Functional Bioassays – Going from 'it works' to how it works

CELL-BASED TECHNOLOGY

Functional Bioassays – Going from 'it works' to how it works

How biosimilars are expanding options for patient care

SVAR CRO SERVICES

How biosimilars are expanding options for patient care

Virtually exploring BEBPA US

Virtually exploring BEBPA US

Complement Activity and Early Screening

COMPLEMENT SYSTEM

Complement Activity and Early Screening

Introducing two new TLR reporter gene cell lines

CELL-BASED TECHNOLOGY

Introducing two new TLR reporter gene cell lines

Updated Guidelines for Paraneoplastic Neurologic Syndromes

WIESLAB DIAGNOSTIC SERVICES

Updated Guidelines for Paraneoplastic Neurologic Syndromes

NEW Collaboration: Wieslab & LabPortalen/InfoSolutions

WIESLAB DIAGNOSTIC SERVICES

NEW Collaboration: Wieslab & LabPortalen/InfoSolutions

Neurofilament Light Chain as a Blood-Based Biomarker for MS

WIESLAB DIAGNOSTIC SERVICES

Neurofilament Light Chain as a Blood-Based Biomarker for MS

Svar partners up to facilitate and support the development of neurodegenerative disease diagnostics and therapeutics

Svar partners up to facilitate and support the development of neurodegenerative disease diagnostics and therapeutics

Autoantibody testing in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

WIESLAB DIAGNOSTIC SERVICES

Autoantibody testing in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Your Expert Partner

SVAR CRO SERVICES

Your Expert Partner

How biomarkers can be valuable tools for making informed decisions

CELL-BASED TECHNOLOGY

How biomarkers can be valuable tools for making informed decisions

EDITORIAL ARTICLE: How functional iLite cells can be used in the quest to find new treatments

CELL-BASED TECHNOLOGY

EDITORIAL ARTICLE: How functional iLite cells can be used in the quest to find new treatments

Pharmacokinetics & Toxicokinetics – tools for making informed drug development decisions

SVAR CRO SERVICES

Pharmacokinetics & Toxicokinetics – tools for making informed drug development decisions

How can MoA & efficacy assays help drug developers make informed decisions?

CELL-BASED TECHNOLOGY

How can MoA & efficacy assays help drug developers make informed decisions?

Informed clinical decisions = safer care

WIESLAB DIAGNOSTIC SERVICES

Informed clinical decisions = safer care

INFORMED DECISIONS - One measurement, worth a thousand expert opinions

INFORMED DECISIONS - One measurement, worth a thousand expert opinions

Covid-19 – Antagonizing the immune system

CELL-BASED TECHNOLOGY

Covid-19 – Antagonizing the immune system

Assistance in development of new innovative therapies

SVAR CRO SERVICES

Assistance in development of new innovative therapies

CASE STUDY: How to Design Potency Assays for Gene Therapy Projects

CELL-BASED TECHNOLOGY

CASE STUDY: How to Design Potency Assays for Gene Therapy Projects

NEW PAPER: Complement components as prognostic markers of the outcome of critically ill COVID-19 patients

COMPLEMENT SYSTEM

NEW PAPER: Complement components as prognostic markers of the outcome of critically ill COVID-19 patients

We’re supporting World Encephalitis Day!

WIESLAB DIAGNOSTIC SERVICES

We’re supporting World Encephalitis Day!

How to identify adverse effect in drug development

SVAR CRO SERVICES

How to identify adverse effect in drug development

They Say Hindsight is 2020…

SVAR CRO SERVICES

They Say Hindsight is 2020…

Finalist for the 19th Malmö Life Science Business Awards!

Finalist for the 19th Malmö Life Science Business Awards!

Want to gain a deeper understanding of drug product safety & efficacy?

SVAR CRO SERVICES

Want to gain a deeper understanding of drug product safety & efficacy?

New Paper: iLite® VEGF and ADCC reporter-gene assays used to analyze samples from patients with ovarian cancer and glioblastoma

New Paper: iLite^® VEGF and ADCC reporter-gene assays used to analyze samples from patients with ovarian cancer and glioblastoma

All eyes on Retinal Gene Therapy

SVAR CRO SERVICES

All eyes on Retinal Gene Therapy

4 ways of measuring Complement function and activation

COMPLEMENT SYSTEM

4 ways of measuring Complement function and activation

New paper: C4d as a lupus nephritis biomarker

COMPLEMENT SYSTEM

New paper: C4d as a lupus nephritis biomarker

Neuronal injury in COVID-19 patients

WIESLAB DIAGNOSTIC SERVICES

Neuronal injury in COVID-19 patients

CD20 – Antibody-based therapeutics & ADCC

CELL-BASED TECHNOLOGY

CD20 – Antibody-based therapeutics & ADCC

A New Cell-based iLite® C5a Assay

COMPLEMENT SYSTEM

A New Cell-based iLite^® C5a Assay

A new functional assay for RANKL

CELL-BASED TECHNOLOGY

A new functional assay for RANKL

EGFR biology, inhibitors & ADCC

CELL-BASED TECHNOLOGY

EGFR biology, inhibitors & ADCC

HER2 and the future of breast cancer immunotherapy

HER2 and the future of breast cancer immunotherapy

mTNF-α antibodies & ADCC analysis

CELL-BASED TECHNOLOGY

mTNF-α antibodies & ADCC analysis

mVEGF inhibition & ADCC activity

CELL-BASED TECHNOLOGY

mVEGF inhibition & ADCC activity

Benefit from ultra-sensitive Simoa HD-X Analyzer™ data

SVAR CRO SERVICES

Benefit from ultra-sensitive Simoa HD-X Analyzer™ data

NfL – a prognostic biomarker of neurodegeneration

WIESLAB DIAGNOSTIC SERVICES

NfL – a prognostic biomarker of neurodegeneration

PRESS RELEASE: Svar Life Science & Nimble Therapeutics Announce Collaboration

PRESS RELEASE: Svar Life Science & Nimble Therapeutics Announce Collaboration

Corona, inflammation and complement activation

COMPLEMENT SYSTEM

Corona, inflammation and complement activation

ONLINE PRESENTATION: IL-6 biology, inhibitors & COVID-19

ONLINE PRESENTATION: IL-6 biology, inhibitors & COVID-19

Wieslab now offers NfL testing in CSF, serum, EDTA-plasma

WIESLAB DIAGNOSTIC SERVICES

Wieslab now offers NfL testing in CSF, serum, EDTA-plasma

Why use C4d as a biomarker?

COMPLEMENT SYSTEM

Why use C4d as a biomarker?

Complement activation and transplantation

COMPLEMENT SYSTEM

Complement activation and transplantation

Helping expand COVID-19 antibody testing capacity

Helping expand COVID-19 antibody testing capacity

IL-6 biology, inhibitors and COVID-19

IL-6 biology, inhibitors and COVID-19

New clinical program for patients with severe COVID-19

New clinical program for patients with severe COVID-19

Svar Life Science Statement on COVID-19

Svar Life Science Statement on COVID-19

The importance of complement biomarkers

COMPLEMENT SYSTEM

The importance of complement biomarkers

The value of Complement Biomarkers in complement therapeutic drug development

COMPLEMENT SYSTEM

The value of Complement Biomarkers in complement therapeutic drug development

Complement therapeutics

COMPLEMENT SYSTEM

Complement therapeutics

The role of the complement system in disease – Too much of a good thing

COMPLEMENT SYSTEM

The role of the complement system in disease – Too much of a good thing

What are Complement Biomarkers?

COMPLEMENT SYSTEM

What are Complement Biomarkers?

3 reasons to study Complement

COMPLEMENT SYSTEM

3 reasons to study Complement

Can ADCC reporter gene assays prove biosimilarity?

Can ADCC reporter gene assays prove biosimilarity?

Wieslab receives ISO 15189 accreditation

WIESLAB DIAGNOSTIC SERVICES

Wieslab receives ISO 15189 accreditation

Proving comparability between biosimilar & innovator drug

CELL-BASED TECHNOLOGY

Proving comparability between biosimilar & innovator drug

ADCC in biosimilar product development

CELL-BASED TECHNOLOGY

ADCC in biosimilar product development

ADCC in vivo vs in vitro

CELL-BASED TECHNOLOGY

ADCC in vivo vs in vitro

The importance of pre-screening gene therapy patients

The importance of pre-screening gene therapy patients

A look at retinal gene therapy

A look at retinal gene therapy

Is gene therapy approved yet?

Is gene therapy approved yet?

What is AAV gene therapy?

What is AAV gene therapy?

Choosing a gene therapy vector

Choosing a gene therapy vector

Design of biosimilar bioanalytical programs: Strategies and perspectives

Design of biosimilar bioanalytical programs: Strategies and perspectives

What is gene therapy and which diseases can it treat?

What is gene therapy and which diseases can it treat?

Introducing: Gene Therapy

Introducing: Gene Therapy

NEW - Order Online

NEW - Order Online

"Cell-line of the month" - IL-23

SVAR CRO SERVICES

"Cell-line of the month" - IL-23

Why do colony stimulating factors have unique biological roles offering therapeutic benefits?

SVAR CRO SERVICES

Why do colony stimulating factors have unique biological roles offering therapeutic benefits?

Introducing iLite Granulocyte Colony-Stimulating Factor (G-CSF) Responsive Cell Line

SVAR CRO SERVICES

Introducing iLite Granulocyte Colony-Stimulating Factor (G-CSF) Responsive Cell Line

Introducing iLite® Assay Ready Cells for IL-2 and IL-6

SVAR CRO SERVICES

Introducing iLite^® Assay Ready Cells for IL-2 and IL-6

Why are interleukins interesting targets in biological drug compounds?

SVAR CRO SERVICES

Why are interleukins interesting targets in biological drug compounds?

Cell line of the month - FGF21

CELL-BASED TECHNOLOGY

Cell line of the month - FGF21

Transitioning into a new brand

New iLite® ADCC Product Line

CELL-BASED TECHNOLOGY

New iLite^® ADCC Product Line

New C4d Complement Assay

COMPLEMENT SYSTEM

New C4d Complement Assay

Nyheter från Wieslab Diagnostic Services

Håll dig uppdaterad med de senaste nyheterna och insikterna från Wieslab. Vi är experter inom diagnostik av autoimmuna och neurologiska sjukdomar.

SVAR LIFE SCIENCE

Contact Form Contact Form
Phone +46 40 53 76 00
Address P.O. Box 50117
SE-202 11, Malmö
Sweden
Visiting Address Lundavägen 151
SE-212 24, Malmö
Sweden

WIESLAB

Contact Form Contact Form
Phone +46 40 53 76 60 (lab)
+46 40 53 76 70 (invoices)
Address P.O. Box 50117
SE-202 11, Malmö
Sweden
Visiting Address Lundavägen 151
SE-212 24, Malmö
Sweden

IMPORTANT LINKS

Privacy and Cookies Cookie Information
Cookie Settings
Privacy Policy
Data Protection Officer (DPO)
Terms & Conditions Terms & Conditions – Svar
Terms & Conditions – Wieslab
Sustainability Find out how we help
Copyright Copyright